Search Results - "Makler, Oryan"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    A consensus introduction to serum replacements and serum-free media for cellular therapies by Karnieli, Ohad, Friedner, Oryan Makler, Allickson, Julie G, Zhang, Nan, Jung, Sunghoon, Fiorentini, David, Abraham, Eytan, Eaker, Shannon S, Yong, tan Kah, Chan, Allan, Griffiths, Sarah, When, Amy k, Oh, Steve

    Published in Cytotherapy (Oxford, England) (01-02-2017)
    “…Abstract The cell therapy industry is a fast-growing industry targeted toward a myriad of clinical indications. As the cell therapy industry matures and…”
    Get full text
    Journal Article
  2. 2

    Direct visualization of the dynamics of antigen presentation in human cells infected with cytomegalovirus revealed by antibodies mimicking TCR specificity by Makler, Oryan, Oved, Kfir, Netzer, Nir, Wolf, Dana, Reiter, Yoram

    Published in European journal of immunology (01-06-2010)
    “…There are no direct means to study class I MHC presentation in human normal or diseased cells. Using CMV‐infected human cells and applying novel mAb that mimic…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Cover Picture: Eur. J. Immunol. 6/10 by Makler, Oryan, Oved, Kfir, Netzer, Nir, Wolf, Dana, Reiter, Yoram

    Published in European journal of immunology (01-06-2010)
    “…The cover image of this issue consists of confocal images of cytomegalovirus‐infected human fibroblast cells stained for HLA‐A2/pp65 complexes, taken from…”
    Get full text
    Journal Article
  5. 5

    A Novel Postpriming Regulatory Check Point of Effector/Memory T Cells Dictated through Antigen Density Threshold-Dependent Anergy by Oved, Kfir, Ziv, Omer, Jacob-Hirsch, Jasmine, Noy, Roy, Novak, Hila, Makler, Oryan, Galit, Denkberg, Keren, Sinik, Segal, Dina, Gefen-Dor, Chen, Amariglio, Ninette, Rechavi, Gideon, Reiter, Yoram

    Published in Journal of Immunology (15-02-2007)
    “…CTLs act as the effector arm of the cell-mediated immune system to kill undesirable cells. Two processes regulate these effector cells to prevent self…”
    Get full text
    Journal Article
  6. 6

    T-cell receptor-like antibodies: novel reagents for clinical cancer immunology and immunotherapy by Noy, Roy, Eppel, Malka, Haus-Cohen, Maya, Klechevsky, Einav, Mekler, Orian, Michaeli, Yael, Denkberg, Galit, Reiter, Yoram

    Published in Expert review of anticancer therapy (01-06-2005)
    “…Major histocompatibility complex class I molecules play a central role in the immune response against a variety of cells that have undergone malignant…”
    Get full text
    Journal Article